Literature DB >> 19897130

CNS complications of radiotherapy and chemotherapy.

Carole Soussain1, Damien Ricard, John R Fike, Jean-Jacques Mazeron, Dimitri Psimaras, Jean-Yves Delattre.   

Abstract

Treatment-induced CNS toxicity remains a major cause of morbidity in patients with cancer. Advances in the design of safe radiation procedures have been counterbalanced by widespread use of combined radiotherapy and chemotherapy, development of radiosurgery, and the increasing number of long-term survivors. Although classic radionecrosis and chemonecrosis have become less common, subtle changes such as progressive cognitive dysfunction are increasingly reported after radiotherapy (radiation-induced leukoencephalopathy) or chemotherapy (given alone or in combination). We review the most important and controversial complications of radiotherapy, chemotherapy, and combined treatments in the CNS, and discuss new diagnostic tools, practical management, prevention, and pathophysiological data that will affect future management of patients with cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897130     DOI: 10.1016/S0140-6736(09)61299-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  106 in total

Review 1.  Whole-brain radiation therapy in breast cancer patients with brain metastases.

Authors:  Cyrus Chargari; François Campana; Jean-Yves Pierga; Lionel Védrine; Damien Ricard; Sylvestre Le Moulec; Alain Fourquet; Youlia M Kirova
Journal:  Nat Rev Clin Oncol       Date:  2010-07-13       Impact factor: 66.675

2.  Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.

Authors:  Amandine Benoit; François Ducray; Stéphanie Cartalat-Carel; Dimitri Psimaras; Damien Ricard; Jérôme Honnorat
Journal:  J Neurol       Date:  2010-09-23       Impact factor: 4.849

3.  The biobehavioral and neuroimmune impact of low-dose ionizing radiation.

Authors:  Jason M York; Neil A Blevins; Daryl D Meling; Molly B Peterlin; Daila S Gridley; Keith A Cengel; Gregory G Freund
Journal:  Brain Behav Immun       Date:  2011-09-21       Impact factor: 7.217

Review 4.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

5.  RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.

Authors:  Zheng Cai; Yongxiang Zou; Hongkang Hu; Chengyin Lu; Wei Sun; Lei Jiang; Guohan Hu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

6.  The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.

Authors:  Joseph M Kim; Jacob A Miller; Rupesh Kotecha; Roy Xiao; Aditya Juloori; Matthew C Ward; Manmeet S Ahluwalia; Alireza M Mohammadi; David M Peereboom; Erin S Murphy; John H Suh; Gene H Barnett; Michael A Vogelbaum; Lilyana Angelov; Glen H Stevens; Samuel T Chao
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

Review 7.  Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy.

Authors:  Mark G Shaw; David L Ball
Journal:  Curr Treat Options Oncol       Date:  2013-12

8.  Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor.

Authors:  J A Molad; D T Blumenthal; F Bokstein; M Findler; I Finkel; N M Bornstein; S Yust-Katz; E Auriel
Journal:  J Neurooncol       Date:  2016-10-18       Impact factor: 4.130

9.  Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation.

Authors:  Fiona L Wilkinson; Ana Sergijenko; Kia J Langford-Smith; Marcela Malinowska; Rob F Wynn; Brian W Bigger
Journal:  Mol Ther       Date:  2013-02-19       Impact factor: 11.454

Review 10.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.